Premier Alternatives

Dr Agarwals Healthcare (NSE: AGARWALEYE)

Chennai, India · Founded 2010 · Publicly Held

Dr Agarwal's Health Care Ltd is engaged in eye care services, including cataract, refractive and other surgeries; consultations, diagnoses and non-surgical treatments; and sell opticals, contact… Dr Agarwals Healthcare (NSE: AGARWALEYE) is based in Chennai, India and was founded in 2010. It is now publicly traded; this page covers its private-market history, where its last recorded valuation was $1.5 billion (Feb 2025). It has raised $136 million.

Last price · $/share
—
Implied valuation
$1.5B
Total raised
$136.4M
Last round
—

Dr Agarwals Healthcare (NSE: AGARWALEYE) key facts

  • Dr Agarwal's Health Care Ltd is engaged in eye care services, including cataract, refractive and other surgeries; consultations, diagnoses and non-surgical treatments; and sell opticals, contact…
  • Dr Agarwals Healthcare (NSE: AGARWALEYE)’s last known valuation is $1.5B (Feb 2025).
  • It has raised $136.4M; the latest was IPO ($350.9M) in Feb 2025.
  • Notable investors include Fidelity, HSBC Holdings, Axis Max Life Insurance, Tiger Pacific Capital (New York), Aditya Birla Sun Life AMC — 17 tracked in total.
  • Status: Publicly Held.
Free account
More of Dr Agarwals Healthcare (NSE: AGARWALEYE) with a free account
  • ·The complete investor list: 17 names
  • ·Watch Dr Agarwals Healthcare (NSE: AGARWALEYE): the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Dr Agarwals Healthcare (NSE: AGARWALEYE) funding rounds

No rounds on record

No funding rounds for Dr Agarwals Healthcare (NSE: AGARWALEYE) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Dr Agarwals Healthcare (NSE: AGARWALEYE) valuation

Dr Agarwals Healthcare (NSE: AGARWALEYE) is now publicly traded; this page covers its private-market history, where its last recorded valuation was $1.5 billion (Feb 2025). Secondary trades, fund marks and rounds below are the private-market record; the listed share price is not tracked here.

Dr Agarwals Healthcare (NSE: AGARWALEYE) investors

17 investors are on record for Dr Agarwals Healthcare (NSE: AGARWALEYE), including Fidelity, HSBC Holdings, Axis Max Life Insurance and Tiger Pacific Capital (New York).

About Dr Agarwals Healthcare (NSE: AGARWALEYE)

Dr Agarwal's Health Care Ltd is engaged in eye care services, including cataract, refractive and other surgeries; consultations, diagnoses and non-surgical treatments; and sell opticals, contact lenses and accessories, and eye care related pharmaceutical products. It offer services such as Surgeries, Cataract surgeries, Refractive surgeries, Other surgeries, and Consultations, diagnoses and non-surgical treatments, Its products services include Sale of opticals and Sale of eye care-related pharmaceutical products. The company is engaged in single segment that is eye care and related services provided from its hospitals which are located in India and Africa. It generates maximum revenue from India.

Sector
Healthcare
HQ
Chennai, India
Founded
2010
Employees
3,371
Ownership
Publicly Held

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.

Valuation on record
$1.5B

Dr Agarwals Healthcare (NSE: AGARWALEYE)’s last known valuation, Feb 2025. A PrivateMarketView mark is published once fund marks, secondary prints or a priced round let us confirm it.